OxDX validating 'deep learning' technology that identifies diseases ‘while you wait’
OxDX has raised £2.6m (US$3.5m) in pre-seed funding to develop AI powered rapid diagnostic technology.
Archives for February 15, 2022
Biologics CDMO market is expanding rapidly but is challenged by capacity constraints
The biologics CDMO market is expected to grow by US$8.65bn from 2021 to 2026, at a CAGR of 12.2% during the forecast period, according to new market data from Technavio.
AffaMed Therapeutics obtains IND clearance for novel retinal biologic
AffaMed Therapeutics has announced that the US FDA has cleared its Investigational New Drug (IND) application for the clinical development of AM712 (ASKG712), a novel proprietary bispecific biologic molecule blocking both vascular endothelial growth...
IASO Bio and Innovent’s BCMA CAR-T cell therapy gains Orphan Drug Designation
IASO Biotherapeutics and Innovent Biologics have announced that the FDA has granted Orphan Drug Designation (ODD) to their fully human anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed...